PRR1 Antibody

What is PRR1 and what role does it play in cellular functions?

PRR1 (also known as Prr1) is a transcription factor that functions as a response regulator in Schizosaccharomyces pombe (fission yeast). It is homologous to the Saccharomyces cerevisiae SKN7 protein and plays a critical role in the cellular response to oxidative stress . PRR1 is constitutively nuclear regardless of cellular conditions and works collaboratively with other transcription factors, particularly Pap1, to regulate specific gene expression patterns . Research has established that PRR1 is essential for the activation of antioxidant genes but not necessarily for drug tolerance genes, suggesting a specialized function in stress response pathways .

How does PRR1 collaborate with other transcription factors?

PRR1 demonstrates a sophisticated collaborative relationship with Pap1, another key transcription factor in S. pombe. This collaboration is particularly evident in their regulatory effects on different gene subsets. For antioxidant genes, PRR1 facilitates the binding of oxidized Pap1 to promoter regions, while Pap1's ability to bind and activate drug tolerance promoters functions independently of PRR1 . This selective collaboration indicates that PRR1 serves as a specificity factor that directs oxidized Pap1 to certain genomic targets. Biochemical evidence suggests that oxidized Pap1 forms a complex with PRR1 in the nucleus, and this interaction is required for the activation of antioxidant genes but not drug tolerance genes .

What are the best applications for PRR1 antibodies in research?

PRR1 antibodies are valuable tools for investigating transcription factor dynamics and protein-protein interactions in stress response pathways. Primary applications include:

• Chromatin immunoprecipitation (ChIP) assays to identify PRR1 binding sites on DNA

• Co-immunoprecipitation experiments to detect protein complexes involving PRR1

• Western blotting to monitor PRR1 expression levels under various conditions

• Immunofluorescence microscopy to visualize PRR1 localization within cells

ChIP experiments have revealed that PRR1 is recruited to both antioxidant and drug tolerance gene promoters after mild oxidative stress in a Pap1-dependent manner . This technique has been crucial for understanding how PRR1 differentially regulates distinct gene sets.

What experimental approaches are most effective for studying PRR1-Pap1 interactions?

Investigating PRR1-Pap1 interactions requires sophisticated experimental approaches that can detect dynamic protein-protein associations in different cellular contexts. Several methodologies have proven effective:

• Co-immunoprecipitation (Co-IP): Research has successfully demonstrated PRR1-Pap1 interactions using GFP-tagged PRR1 for immunoprecipitation followed by detection with polyclonal antibodies against Pap1 . This approach revealed that the interaction between these proteins is dependent on the oxidation state of Pap1.

• Chromatin Immunoprecipitation (ChIP): ChIP experiments have shown that PRR1 is recruited to promoters in a Pap1-dependent manner, but only when Pap1 is in its oxidized form . The technique involves:

  • Crosslinking proteins to DNA

  • Fragmenting chromatin

  • Immunoprecipitating with PRR1 antibodies

  • Analyzing associated DNA sequences by PCR or sequencing

• Fluorescence microscopy with tagged proteins: Studies have utilized GFP-tagged PRR1 to determine its relative abundance compared to HA-tagged Pap1, revealing that PRR1 is slightly more abundant than Pap1 in cells .

• Genetic approaches: Creating strains with mutations in either PRR1 or Pap1 has been instrumental in dissecting their functional relationship. For instance, strains lacking PRR1 (Δprr1) show normal Pap1 oxidation but impaired recruitment of Pap1 to antioxidant gene promoters .

How can researchers distinguish between PRR1-dependent and PRR1-independent gene expression?

Differentiating between PRR1-dependent and PRR1-independent gene expression requires a systematic experimental approach:

• Generate PRR1 deletion strains: Create Δprr1 strains while maintaining wild-type Pap1 function.

• Perform gene expression analysis: Compare gene expression profiles between wild-type and Δprr1 strains under various conditions (basal, oxidative stress, drug exposure) using:

  • RT-qPCR for candidate genes

  • RNA-seq for genome-wide expression patterns

  • Reporter gene assays for specific promoter activities

• Analyze promoter binding: Conduct ChIP experiments to examine Pap1 binding to different promoters in the presence and absence of PRR1.

Research has established that PRR1 is essential for the activation of antioxidant genes like ctt1 and srx1 but dispensable for drug tolerance genes such as caf5, obr1, and SPCC663.08c . This distinction is critical for understanding the specialized roles of these transcription factors in different stress response pathways.

What factors affect PRR1 antibody specificity and how can cross-reactivity be minimized?

Antibody specificity is crucial for accurate PRR1 detection. Several factors influence specificity and steps can be taken to minimize cross-reactivity:

• Epitope selection: Choose unique regions of PRR1 that have minimal homology with related proteins. Careful bioinformatic analysis of protein sequences can identify regions that are distinct from other transcription factors or response regulators.

• Validation strategies:

  • Use PRR1 knockout/deletion strains as negative controls

  • Perform peptide competition assays

  • Test antibodies in multiple applications (Western blot, IP, ChIP, immunofluorescence)

• Optimization techniques:

  • Adjust antibody concentrations to minimize background

  • Modify blocking conditions to reduce non-specific binding

  • Optimize wash stringency in immunoprecipitation experiments

• Cross-adsorption: Pre-adsorb antibodies with lysates from cells lacking PRR1 to remove antibodies that bind to other proteins.

Research practices indicate that monoclonal antibodies generally offer higher specificity than polyclonal antibodies, though the latter may provide better sensitivity for detecting native PRR1 in certain applications .

How does oxidative stress affect PRR1 function and what methods best capture these dynamics?

Oxidative stress significantly impacts PRR1 function, particularly in its collaboration with Pap1. The following methodological approaches are effective for studying these dynamics:

• Real-time monitoring of PRR1-promoter interactions: ChIP experiments under controlled oxidative stress conditions have revealed that PRR1 is recruited to promoters after mild oxidative stress in a Pap1-dependent manner .

• Sequential ChIP (Re-ChIP): This technique can determine whether PRR1 and oxidized Pap1 simultaneously occupy the same promoter regions by performing consecutive immunoprecipitations with antibodies against each protein.

• Protein oxidation state analysis: While PRR1 itself does not appear to undergo oxidation, its functional partner Pap1 does. The oxidation state of Pap1 can be analyzed using:

  • Non-reducing SDS-PAGE to detect mobility shifts

  • Mass spectrometry to identify oxidized residues

  • Redox-sensitive fluorescent protein fusions

• Temporal resolution experiments: Time-course studies following oxidative stress induction have shown that PRR1 facilitates binding of oxidized Pap1 to antioxidant gene promoters but is not required for Pap1 binding to drug tolerance gene promoters .

Research has demonstrated that PRR1 is only recruited to DNA by oxidized Pap1, as evidenced by experiments with cells lacking Trr1 (which display constitutive binding of PRR1 to promoters) versus cells expressing Pap1.C523D (which cannot be oxidized and fail to recruit PRR1 to DNA) .

What are the optimal conditions for using PRR1 antibodies in ChIP experiments?

Chromatin immunoprecipitation with PRR1 antibodies requires careful optimization to achieve reliable results. Based on successful ChIP protocols in the literature, the following conditions are recommended:

• Crosslinking parameters:

  • Use 1% formaldehyde for 10-15 minutes at room temperature

  • Quench with 125 mM glycine

• Chromatin fragmentation:

  • Sonicate to achieve fragments of 200-500 bp

  • Verify fragmentation efficiency by agarose gel electrophoresis

• Immunoprecipitation conditions:

  • Pre-clear chromatin with protein A/G beads

  • Use 2-5 μg of PRR1 antibody per ChIP reaction

  • Incubate overnight at 4°C with rotation

• Washing stringency:

  • Perform increasingly stringent washes to remove non-specific binding

  • Include a high-salt wash step to reduce background

• Controls:

  • Include IgG control immunoprecipitations

  • Perform parallel ChIP with known targets as positive controls

  • Use PRR1-deficient cells as negative controls

ChIP experiments have successfully demonstrated that PRR1 binds to both antioxidant and drug tolerance gene promoters after oxidative stress, but only in the presence of oxidized Pap1 .

How can researchers quantitatively assess PRR1-Pap1 interactions?

Quantitative assessment of PRR1-Pap1 interactions requires specialized techniques that can detect and measure protein-protein associations:

• Quantitative co-immunoprecipitation:

  • Immunoprecipitate with either PRR1 or Pap1 antibodies

  • Quantify co-precipitated proteins by western blotting with densitometry

  • Calculate enrichment ratios relative to input controls

• Bio-Layer Interferometry (BLI):

  • Similar to the technique used for analyzing antibody binding kinetics

  • Can determine association and dissociation rates between purified PRR1 and Pap1

  • Provides quantitative binding constants (KD values)

• Förster Resonance Energy Transfer (FRET):

  • Tag PRR1 and Pap1 with compatible fluorophores

  • Measure energy transfer as an indicator of protein proximity

  • Quantify interaction strength under different conditions

• Proximity Ligation Assay (PLA):

  • Detect protein interactions in situ with high sensitivity

  • Visualize individual interaction events as fluorescent spots

  • Quantify spot numbers to assess interaction frequency

Research has established that PRR1 and Pap1 interact in vivo, with oxidized Pap1 forming a complex with PRR1 in the nucleus. Quantitative analysis has shown that PRR1 is slightly more abundant than Pap1 in cells, suggesting that all Pap1 molecules could potentially associate with PRR1 when accumulated in the nucleus .

What approaches effectively distinguish between PRR1 and other similar transcription factors?

Distinguishing PRR1 from related transcription factors requires carefully designed experimental approaches:

• Antibody epitope mapping:

  • Generate antibodies against unique regions of PRR1

  • Perform peptide array analysis to confirm binding specificity

  • Test cross-reactivity with purified related proteins

• Mass spectrometry-based identification:

  • Use immunoprecipitation followed by mass spectrometry

  • Analyze peptide fingerprints to distinguish PRR1 from related proteins

  • Identify post-translational modifications specific to PRR1

• DNA binding specificity analysis:

  • Perform ChIP-seq to identify genome-wide binding patterns

  • Compare binding motifs with those of related transcription factors

  • Use competitive DNA binding assays to assess relative affinities

• Genetic approaches:

  • Create strains with epitope-tagged versions of PRR1 and related factors

  • Perform sequential ChIP to determine co-occupancy or mutual exclusivity

  • Use CRISPR-Cas9 to introduce specific mutations that affect only PRR1

Research has demonstrated that PRR1 has distinct functional roles compared to other transcription factors. While Pap1 can bind and activate drug tolerance promoters independently, its ability to activate antioxidant promoters significantly depends on PRR1 , highlighting their unique relationship and specific functions.

What are common challenges in PRR1 antibody experiments and how can they be overcome?

Researchers working with PRR1 antibodies frequently encounter several challenges:

• Low signal-to-noise ratio:

  • Solution: Optimize antibody concentration and incubation conditions

  • Approach: Perform titration experiments to determine optimal antibody dilutions

  • Alternative: Consider using more sensitive detection methods such as tyramide signal amplification

• Non-specific binding:

  • Solution: Increase blocking stringency and washing steps

  • Approach: Use alternative blocking agents (BSA, milk, normal serum)

  • Verification: Confirm specificity using PRR1 knockout controls

• Inconsistent ChIP results:

  • Solution: Standardize crosslinking and sonication conditions

  • Approach: Optimize chromatin fragmentation for consistent fragment sizes

  • Control: Include spike-in chromatin controls for normalization

• Detecting transient interactions:

  • Solution: Use rapid crosslinking methods

  • Approach: Consider proximity-based labeling techniques like BioID or APEX

  • Alternative: Stabilize interactions with chemical crosslinkers before immunoprecipitation

Research demonstrates that PRR1 interactions with Pap1 are dependent on the oxidation state of Pap1 , making timing and experimental conditions crucial for detecting these associations.

How can PRR1 antibodies be used to study the dynamics of oxidative stress response?

PRR1 antibodies can provide valuable insights into oxidative stress response dynamics through several advanced applications:

• Time-course ChIP experiments:

  • Monitor PRR1 recruitment to promoters at different time points after oxidative stress

  • Compare binding kinetics between antioxidant and drug tolerance genes

  • Correlate PRR1 binding with gene expression changes

• Proximity-based protein interaction studies:

  • Use split reporter systems (BiFC, SPARK) with PRR1 antibodies

  • Detect PRR1-Pap1 interactions in real-time following oxidative stress

  • Map the cellular localization of interaction events

• Combined ChIP-seq and RNA-seq analysis:

  • Integrate genome-wide PRR1 binding data with transcriptome changes

  • Identify direct and indirect targets of PRR1 regulation

  • Construct temporal networks of transcriptional responses

• Single-cell analysis:

  • Apply PRR1 antibodies in immunofluorescence microscopy

  • Measure cell-to-cell variability in PRR1 localization and function

  • Correlate with single-cell RNA-seq data to understand population heterogeneity

Research has established that PRR1 facilitates binding of oxidized Pap1 to antioxidant gene promoters following H₂O₂ stress . This dynamic interaction is crucial for the proper activation of genes involved in the oxidative stress response.

What emerging technologies are enhancing PRR1 antibody research?

Several cutting-edge technologies are advancing PRR1 antibody research:

• CUT&RUN and CUT&Tag:

  • More sensitive alternatives to traditional ChIP

  • Require fewer cells and less antibody

  • Provide higher signal-to-noise ratio for detecting PRR1 binding sites

• Genomic engineering with CRISPR-Cas9:

  • Generate endogenously tagged PRR1 variants

  • Create precise mutations to study structure-function relationships

  • Develop cellular reporters for PRR1 activity

• Advanced protein visualization techniques:

  • Super-resolution microscopy to visualize PRR1 localization at nanometer scale

  • Live-cell imaging with genetically encoded fluorescent tags

  • Single-molecule tracking to monitor PRR1 dynamics in real-time

• Integrative multi-omics approaches:

  • Combine PRR1 ChIP-seq, RNA-seq, and proteomics data

  • Map comprehensive networks of PRR1-regulated pathways

  • Model dynamic responses to oxidative stress at systems level

These technologies enable researchers to study PRR1 function with unprecedented resolution and provide deeper insights into its role in transcriptional regulation and cellular stress responses.

What are the most promising avenues for future PRR1 antibody research?

Based on current knowledge and emerging technologies, several promising research directions for PRR1 antibodies include:

• Structure-function studies:

  • Investigate how PRR1-Pap1 interactions are structurally mediated

  • Examine how oxidation of Pap1 affects its interaction with PRR1

  • Develop antibodies that specifically recognize different functional states of PRR1

• Systems-level analysis:

  • Map the complete PRR1 interactome under different stress conditions

  • Identify all genomic targets of PRR1 across different cellular states

  • Develop comprehensive models of PRR1-dependent transcriptional networks

• Translational applications:

  • Explore the conservation of PRR1-like functions in mammalian systems

  • Investigate potential roles in disease-relevant oxidative stress responses

  • Develop PRR1-targeted approaches for modulating stress resistance

• Methodological advances:

  • Create nanobodies or single-domain antibodies against PRR1 for improved access to nuclear targets

  • Develop proximity-labeling approaches to identify transient PRR1 interactions

  • Establish quantitative imaging techniques for measuring PRR1 dynamics in living cells

Current research has established that PRR1 plays a crucial role in facilitating the binding of oxidized Pap1 to antioxidant gene promoters , suggesting that targeting this interaction could provide new ways to modulate cellular responses to oxidative stress.

How might PRR1 antibodies contribute to understanding broader transcriptional regulation mechanisms?

PRR1 antibodies offer unique opportunities to investigate fundamental aspects of transcriptional regulation:

• Cooperative transcription factor interactions:

  • Study how PRR1 and Pap1 collaborate to recognize specific promoters

  • Investigate the principles governing transcription factor partnerships

  • Determine how oxidative modifications influence transcription factor cooperation

• Stress-responsive transcriptional programs:

  • Compare PRR1-mediated responses to different types of cellular stress

  • Examine how PRR1 contributes to stress memory and adaptation

  • Identify conserved principles of stress-responsive transcription

• Evolutionary perspectives:

  • Investigate the conservation of PRR1-like functions across species

  • Compare PRR1 binding motifs and interacting partners between organisms

  • Understand how transcription factor collaborations evolved to respond to environmental challenges

• Chromatin context influences:

  • Examine how PRR1 binding is affected by chromatin structure

  • Investigate potential interactions with chromatin modifiers

  • Determine how nucleosome positioning affects PRR1-Pap1 recruitment

Research has demonstrated that PRR1 facilitates binding of oxidized Pap1 to one subset of promoters but not others , suggesting complex mechanisms governing promoter selectivity that likely involve chromatin context and additional regulatory factors.